Attached files

file filename
8-K - CURRENT REPORT - AMERIGROUP CORPv319973_8k.htm

Amerigroup Reports Second Quarter 2012 Results



Revenues of $2.23 Billion, a 45.8% Increase Year-Over-Year



Net Income of $32.0 Million or $0.63 per Diluted Share

VIRGINIA BEACH, Va., Aug. 1, 2012 /PRNewswire/ -- Amerigroup Corporation (NYSE: AGP) today announced that net income for the second quarter of 2012 was $32.0 million, or $0.63 per diluted share, versus $44.3 million, or $0.83 per diluted share, for the second quarter of 2011 and compared to $33.1 million, or $0.64 per diluted share, for the first quarter of 2012. Total revenues for the second quarter of 2012 increased 45.8% to $2.23 billion compared with $1.53 billion in the second quarter of 2011. Sequentially, total revenues increased $459 million, or 26.0%, from the first quarter of 2012.

In July, the Company received approval of its rate increase in New York, which is retroactive to April 1, 2012. The Company expects to recognize premium revenue of approximately $5.4 million, or $0.06 earnings per diluted share including the impact of premium tax, in the third quarter of 2012 for the retroactive portion of the rate increase associated with the second quarter.

On July 9, 2012, Amerigroup announced the execution of a definitive agreement pursuant to which WellPoint, Inc. will acquire Amerigroup. As previously announced, the transaction is expected to close in the first quarter of 2013.

Highlights include:

  • Membership increased 512,000 members, or 23.6%, to approximately 2.7 million at the end of the second quarter of 2012 compared to the first quarter of 2012. 
  • Health benefits expense was 86.9% of premium revenue for the second quarter of 2012. 
  • Selling, general and administrative expenses were 7.7% of total revenues for the second quarter of 2012.
  • Cash flow from operations was $72.1 million for the three months ended June 30, 2012 and $103 million for the six months ended June 30, 2012.
  • Unregulated cash and investments were $427 million as of June 30, 2012 compared to $824 million as of March 31, 2012.
  • Medical claims payable as of June 30, 2012 totaled $686 million compared to $618 million as of March 31, 2012.
  • On May 1, 2012, Amerigroup closed the previously announced acquisition of Health Plus in New York.
  • On June 1, 2012, Amerigroup began serving members in the third of three regions in Louisiana. 
  • In June 2012, Amerigroup announced that it expects to begin operations in the state of Kansas during the first quarter of 2013 following a successful competitive bid.
  • On July 1, 2012, Amerigroup began serving members in its 13th state, Washington. 

"We are pleased with our growth in the quarter as a result of closing the Health Plus transaction and going live in the last of the three regions in Louisiana," saidJames G. Carlson, Amerigroup's chairman and chief executive officer.

Premium Revenue
Premium revenue for the second quarter of 2012 increased 45.7% to $2.22 billion versus $1.52 billion in the second quarter of 2011. Sequentially, premium revenue increased $458 million, or 26.0%.

The sequential increase in premium revenue primarily reflects increased membership due to the May 1 closing of the Health Plus acquisition in New York, a full quarter of premiums related to the expanded benefits and geographic presence in Texas, and the entry into the second and third of three regions in Louisiana.

Investment Income and Other Revenues
Second quarter investment income and other revenues were $8.0 million versus $4.0 million in the second quarter of 2011, and compared to $7.4 million in the first quarter of 2012.

Health Benefits
Health benefits expense, as a percent of premium revenue, was 86.9% for the second quarter of 2012 versus 84.1% in the second quarter of 2011, and compared to 85.3% in the first quarter of 2012.

Selling, General and Administrative Expenses
Selling, general and administrative expenses were 7.7% of total revenues for the second quarter of 2012 versus 8.0% in the second quarter of 2011, and compared to 8.4% for the first quarter of 2012.

Premium Taxes
Second quarter 2012 premium taxes were $51.8 million versus $40.4 million for the second quarter of 2011, and compared to $43.4 million in the first quarter of 2012.

Balance Sheet Highlights
Cash and investments at June 30, 2012 totaled $2.02 billion of which $427 million was unregulated compared to $824 million of unregulated cash and investments at March 31, 2012. The sequential decrease in unregulated cash and investments was primarily due to the $260 million paid in satisfaction of the Company's 2.0% convertible notes in May 2012 and payment of the $85 million transaction price for the Health Plus acquisition.

The debt-to-total capital ratio decreased to 25.7% as of June 30, 2012 from 35.5% at March 31, 2012 as a result of the satisfaction of the Company's obligations with respect to its 2.0% convertible senior notes.

Medical claims payable as of June 30, 2012 totaled $686 million compared to $618 million as of March 31, 2012.

Included on page 10 is a table presenting the components of the change in medical claims payable for each of the six-month periods ended June 30, 2012 and 2011.

Cash Flow Highlights
Cash flow from operations totaled $72.1 million for the three months ended June 30, 2012, compared to $31.1 million in the second quarter of 2011. Cash flow in the quarter was positively impacted by a net favorable change in working capital accounts.

Proposed Merger
On July 9, 2012, Amerigroup and WellPoint announced that they entered into a definitive agreement through which WellPoint will acquire Amerigroup. Under the terms of the agreement, WellPoint will pay $92.00 per share in cash to acquire all of the outstanding shares of Amerigroup for a transaction value of approximately $4.9 billion.

The transaction is subject to certain state regulatory approvals and standard closing conditions and customary approvals required under the Hart-Scott-Rodino Antitrust Improvements Act and the approval of Amerigroup's stockholders.

The transaction is expected to close in the first quarter of 2013.

Second Quarter Earnings Call and Outlook
Due to the definitive agreement with WellPoint, the Company will no longer be hosting a conference call regarding second quarter results. In addition, the Company will not be revising or updating previously issued full-year 2012 outlook parameters.

About Amerigroup Corporation
Amerigroup, a Fortune 500 company, coordinates services for individuals in publicly funded health care programs. Currently serving approximately 2.7 million members in 13 states nationwide, Amerigroup expects to expand operations to Kansas as a result of a previously awarded state contract. Amerigroup is dedicated to offering real solutions that improve health care access and quality for its members, while proactively working to reduce the overall cost of care to taxpayers. Amerigroup accepts all eligible people regardless of age, sex, race or disability.

Forward-Looking Statements
This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the Securities and Exchange Commission's Fair Disclosure Regulation. This release contains certain ''forward-looking'' statements, including those with respect to our growth plans, the pending transaction with WellPoint and expansion into the state of Kansas, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. These risks and uncertainties include, but are not limited to: the failure to receive, on a timely basis or otherwise, the required approvals by Amerigroup's stockholders and government or regulatory agencies; the risk that a condition to closing of the proposed transaction may not be satisfied; Amerigroup's and WellPoint's ability to consummate the Merger; the failure by WellPoint to obtain the necessary debt financing arrangements set forth in the commitment letter received in connection with the Merger; operating costs and business disruption may be greater than expected; the ability of Amerigroup to retain and hire key personnel and maintain relationships with providers or other business partners pending the consummation of the transaction; our inability to manage medical costs; our inability to operate new products and markets at expected levels, including, but not limited to, profitability, membership and targeted service standards; local, state and national economic conditions, including their effect on the periodic premium rate change process and timing of payments; the effect of laws and regulations governing the health care industry, including the Patient Protection and Affordable Care Act, as amended by the Healthcare and Education Reconciliation Act of 2010, and any regulations enacted there under; changes in Medicaid and Medicare payment levels and methodologies; increased use of services, increased cost of individual services, pandemics, epidemics, the introduction of new or costly treatments and technology, new mandated benefits, insured population characteristics and seasonal changes in the level of health care use; our ability to maintain and increase membership levels; our ability to enter into new markets or remain in existing markets; changes in market interest rates or any disruptions in the credit markets; our ability to maintain compliance with all minimum capital requirements; liabilities and other claims asserted against us; demographic changes; the competitive environment in which we operate; the availability and terms of capital to fund acquisitions, capital improvements and maintain capitalization levels required by regulatory agencies; our ability to attract and retain qualified personnel; the unfavorable resolution of new or pending litigation; and catastrophes, including acts of terrorism or severe weather.

Investors should also refer to our annual report on Form 10-K for the year ended December 31, 2011 filed with the Securities and Exchange Commission ("SEC") and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause our actual results to differ materially from our current estimates. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. We specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

AMERIGROUP CORPORATION AND SUBSIDIARIES


CONDENSED CONSOLIDATED INCOME STATEMENTS


(dollars in thousands, except per share data)


(unaudited)

















Three months ended



Six months ended




June 30,



June 30,




2012



2011



2012



2011















Revenues:













Premium 


$2,219,238



$1,523,433



$3,980,043



$3,059,228


Investment income and other


7,955



4,001



15,346



8,121


Total revenues 


2,227,193



1,527,434



3,995,389



3,067,349


Expenses:













Health benefits


1,929,098



1,281,760



3,430,251



2,538,722


Selling, general and administrative 


171,412



122,289



319,365



238,748


Premium taxes


51,818



40,439



95,207



80,887


Depreciation and amortization 


12,290



9,332



23,190



18,422


Interest 


10,651



4,170



22,716



8,349


Total expenses 


2,175,269



1,457,990



3,890,729



2,885,128


Income before income taxes 


51,924



69,444



104,660



182,221


Income tax expense


19,900



25,150



39,550



67,450


Net income


$32,024



$44,294



$65,110



$114,771




























Diluted net income per share 


$0.63



$0.83



$1.27



$2.18















Weighted average number of common shares and dilutive potential common shares outstanding


50,439,487



53,541,368



51,170,927



52,658,303






















































The following table sets forth selected operating ratios.  All ratios, with the exception of the health benefits ratio, are shown as a percentage of total revenues. 


















Three months ended



Six months ended



June 30,



June 30,



2012



2011



2012



2011


Premium revenue 


99.6%



99.7%



99.6%



99.7%


Investment income and other


0.4%



0.3%



0.4%



0.3%


Total revenues 


100.0%



100.0%



100.0%



100.0%


Health benefits [1] 


86.9%



84.1%



86.2%



83.0%


Selling, general and administrative expenses


7.7%



8.0%



8.0%



7.8%


Income before income taxes 


2.3%



4.5%



2.6%



5.9%


Net income


1.4%



2.9%



1.6%



3.7%















[1] The health benefits ratio is shown as a percentage of premium revenue because there is a direct relationship between the premium received and the health benefits provided.











The following table sets forth the approximate number of members the Company served in each state as of June 30, 2012 and 2011.  Because the Company receives two premiums for members that are both in the Medicare Advantage and Medicaid products, these members have been counted twice in the states where we offer both plans.











June 30,








2012


2011




Texas




769,000


593,000




New York




434,000


109,000




Georgia




287,000


270,000




Florida




266,000


262,000




Maryland  




213,000


207,000




Tennessee




205,000


205,000




New Jersey 




154,000


133,000




Louisiana




143,000


N/A




Nevada




85,000


86,000




Ohio




57,000


55,000




Virginia




48,000


40,000




New Mexico




24,000


22,000




      Total  




2,685,000


1,982,000













The following table sets forth the approximate number of members in each of the Company's products as of June 30, 2012 and 2011.  Because the Company receives two premiums for members that are in both the Medicare Advantage and Medicaid products, these members have been counted in each product.

































June 30,


Product






2012


2011


TANF (Medicaid)






1,888,000


1,405,000


Aged, Blind and Disabled and Long-Term Care (Medicaid)






317,000


216,000


CHIP






316,000


266,000


FamilyCare (Medicaid)






128,000


74,000


Medicare Advantage 






36,000


21,000


Total 






2,685,000


1,982,000












AMERIGROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in thousands, except per share data)

(unaudited)


June 30,


December 31,


2012


2011







Assets

Current assets:




Cash and cash equivalents

$624,330


$546,811

Short-term investments  

157,657


394,346

Premium receivables  

312,183


106,510

Deferred income taxes  

28,253


24,720

Prepaid expenses, provider and other receivables and other 

99,208


93,373

Total current assets 

1,221,631


1,165,760





Long-term investments, including investments on deposit for licensure

1,242,404


1,246,190

Property, equipment and software, net 

121,939


110,602

Goodwill 

316,747


260,496

Other long-term assets  

44,580


18,300


$2,947,301


$2,801,348





Liabilities and Stockholders' Equity

Current liabilities:




Claims payable 

$686,498


$573,448

Unearned revenue 

93,043


780

Contractual refunds payable

44,241


40,123

Accounts payable, accrued expenses and other 

233,006


212,828

Current portion of long-term convertible debt

-


256,995

Total current liabilities 

1,056,788


1,084,174





Long-term debt 

477,648


400,000

Other long-term liabilities

34,764


32,655

Total liabilities 

1,569,200


1,516,829





Stockholders' equity:




Common stock, $.01 par value

598


573

Additional paid-in capital, net of treasury stock 

238,823


212,380

Accumulated other comprehensive income

13,946


11,942

Retained earnings 

1,124,734


1,059,624

Total stockholders' equity 

1,378,101


1,284,519


$2,947,301


$2,801,348





AMERIGROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in thousands)

(unaudited)


Six months ended

June 30,


2012


2011



Cash flows from operating activities:




Net income 

$65,110


$114,771

Adjustments to reconcile net income to net cash provided by




operating activities:




Depreciation and amortization 

23,190


18,422

Loss on disposal of property, equipment and software

79


320

Deferred tax benefit

(1,566)


(144)

Compensation expense related to share-based payments

13,685


10,757

Non-cash interest expense

3,164


5,682

Other

5,825


7,263

Changes in assets and liabilities (decreasing) increasing cash




flows from operations:




Premium receivables 

(205,673)


(31,616)

Prepaid expenses, provider and other receivables and other




current assets

(4,354)


(28,722)

Other long-term assets 

(1,737)


(2,106)

Claims payable

113,050


8,833

Accounts payable, accrued expenses, contractual refund payable




and other current liabilities

1,625


10,653

Unearned revenue 

92,263


1,146

Other long-term liabilities

(1,545)


(606)

Net cash provided by operating activities 

103,116


114,653





Cash flows from investing activities:




Proceeds from (purchase of) investments, net

296,238


(257,487)

Purchase of property, equipment and software 

(28,862)


(20,170)

Purchase of investments on deposit for licensure, net

(54,458)


(10,232)

Purchase of contract rights and other related assets

(85,168)


-

Net cash provided by (used in) investing activities 

127,750


(287,889)





Cash flows from financing activities:




Proceeds from issuance of long-term debt

77,813


-

Issuance costs of long-term debt

(1,061)


-

Repayment of convertible notes principal

(259,880)


-

Change in bank overdrafts

12,553


16,262

Proceeds and tax benefits from exercise of stock options 




and other, net

17,228


55,796

Repurchase of common stock shares

-


(79,997)

Net cash used in financing activities

(153,347)


(7,939)

Net increase (decrease) in cash and cash equivalents

77,519


(181,175)

Cash and cash equivalents at beginning of period

546,811


763,946

Cash and cash equivalents at end of period

$624,330


$582,771





AMERIGROUP CORPORATION AND SUBSIDIARIES

Components of the Change in Medical Claims Payable

(dollars in thousands)







Six months ended



June 30, 



2012


2011


Medical claims payable, beginning of period

$573,448


$510,675







Health benefits expenses incurred during period:





Related to current year

3,528,233


2,613,310


Related to prior years

(97,982)


(74,588)


Total incurred

3,430,251


2,538,722







Health benefits payments during period:





Related to current year

2,880,028


2,168,850


Related to prior years

437,173


361,039


Total payments

3,317,201


2,529,889







Medical claims payable, end of period

$686,498


$519,508







Health benefits expenses incurred during both periods were reduced for amounts related to prior years.  The amounts related to prior years include the impact of amounts previously included in the liability to establish it at a level sufficient under moderately adverse conditions that were not needed and the reduction in health benefits expenses due to revisions to prior estimates. 



CONTACTS:


Investors: Julie Loftus Trudell

News Media: Maureen C. McDonnell

Amerigroup Corporation

Amerigroup Corporation

Senior Vice President, Investor Relations

Vice President, External Communications

(757) 321-3597

(757) 473-2731

Julie.Trudell@amerigroup.com

Maureen.McDonnell@amerigroup.com